1. Protective effect of mitochondria-targeted antioxidants in an acute bacterial infection.
- Author
-
Plotnikov EY, Morosanova MA, Pevzner IB, Zorova LD, Manskikh VN, Pulkova NV, Galkina SI, Skulachev VP, and Zorov DB
- Subjects
- Animals, Antioxidants therapeutic use, Blotting, Western, Cells, Cultured, Drug Delivery Systems methods, Escherichia coli, Immunohistochemistry, Microscopy, Electron, Scanning, Mitochondria metabolism, Peroxidase metabolism, Plastoquinone pharmacology, Plastoquinone therapeutic use, Pyelonephritis pathology, Rats, Rhodamines therapeutic use, Antioxidants pharmacology, Mitochondria drug effects, Oxidative Stress physiology, Plastoquinone analogs & derivatives, Proto-Oncogene Proteins c-bcl-2 metabolism, Pyelonephritis drug therapy, Reactive Oxygen Species metabolism, Rhodamines pharmacology
- Abstract
Acute pyelonephritis is a potentially life-threatening infection of the upper urinary tract. Inflammatory response and the accompanying oxidative stress can contribute to kidney tissue damage, resulting in infection-induced intoxication that can become fatal in the absence of antibiotic therapy. Here, we show that pyelonephritis was associated with oxidative stress and renal cell death. Oxidative stress observed in pyelonephritic kidney was accompanied by a reduced level of mitochondrial B-cell lymphoma 2 (Bcl-2). Importantly, renal cell death and animal mortality were both alleviated by mitochondria-targeted antioxidant 10(6'-plastoquinonyl) decylrhodamine 19 (SkQR1). These findings suggest that pyelonephritis can be treated by reducing mitochondrial reactive oxygen species and thus by protecting mitochondrial integrity and lowering kidney damage.
- Published
- 2013
- Full Text
- View/download PDF